Background
==========

There are symptoms common to both chronic heart failure (CHF) and pulmonary arterial hypertension (PAH). The heart, lungs, kidneys, and muscles are affected in both diseases. Pulmonary abnormalities play an important role in the evaluation and prognosis of CHF and PAH. The differences of pulmonary function in chronic left heart failure and chronic right heart failure are not fully understood.

Cardiopulmonary exercise testing (CPX) is considered the criterion standard for studying cardiovascular, pulmonary, and metabolic adaptations to exercise in heart disease. Pulmonary abnormalities occur in both CHF and chronic right heart failure secondary to PAH \[[@b1-medscimonit-20-960]--[@b9-medscimonit-20-960]\]. Left heart failure with cardiac enlargement causes restrictive lung disease, interstitial edema, alveolar-capillary hydrostatic injury, and fatigue of respiratory muscles, which contributes to pulmonary abnormalities. PAH can cause ventilation/perfusion (V/Q) inequality secondary to pulmonary vascular bed damage. Hyperventilation may result from these pulmonary function changes.

We hypothesized that pulmonary function is different in patients with left heart failure and right heart failure secondary to PAH. This study may help understand relationships between pulmonary abnormalities and different types of heart failure.

Material and Methods
====================

Patients
--------

A single cardiologist evaluated 120 patients with clinically stable CHF, including 60 patients with chronic left heart failure and 60 patients with chronic right heart failure. Left heart failure was diagnosed using the American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) guidelines for heart failure \[[@b10-medscimonit-20-960]\]. PAH was defined as WHO group1 PH according to the ACCF/AHA expert consensus document on pulmonary hypertension. We excluded patients with group 2, 3, 4, or 5, associated with congenital heart disease, portal hypertension, significant venous or capillary involvement, or persistent pulmonary hypertension of the newborn \[[@b11-medscimonit-20-960]\]. Right heart failure was defined as PAH and cardiac index (CI) \<2.2 L/(min×m^2^) as measured by right heart catheterization. All patients had symptoms and/or signs of right heart failure. All patients had a forced expiratory volume in 1 s/forced vital capacity (FEV1/FVC) ratio \>65% at rest. All testing was performed before treatment.

The study protocol adhered to the Declaration of Helsinki. Each patient provided written informed consent to participate in this study. The document was approved and recorded by the institutional Ethics Committee of Fuwai Hospital, China. The project approval number was 2012-401.

Pulmonary function test at rest
-------------------------------

Pulmonary function testing at rest was performed using a closed-circuit spirometer (COSMED, Italy) according to the American Thoracic Society (ATS) recommendations \[[@b12-medscimonit-20-960]\]. Dead space volume/tidal volume (VD/VT)=(PaCO~2~ -- PECO~2~ mean)/PaCO~2~ -- \[VD (machine)/VT\] where PaCO~2~ = arterial CO~2~ tension, PECO~2~ = the partial pressure of expired CO~2~. Minute ventilation/CO~2~ production (VE/VCO~2~) ratio was defined as VE/VCO~2~ = 863/\[PaCO~2~ × (1-VD/VT)\].

Cardiopulmonary exercise testing
--------------------------------

Physician-supervised CPX was performed on a bicycle ergometer with a breath-by-breath system (COSMED, Italy) according to the ATS/American College of Chest Physicians (ACCP) Statement on CPX \[[@b13-medscimonit-20-960]\]. Exercise-induced right-to-left shunt (EIS) was performed according to criteria described by Sun \[[@b14-medscimonit-20-960]\].

Breathing reserve (BR) was defined as: BR = (MVV-peak VE)/MVV ×100% where MVV = maximal voluntary ventilation.

Change in CPX parameter from rest to peak exercise was defined as: Δ measure = (peak measure-rest measure)/rest measure ×100%.

Echocardiography
----------------

Two-dimensional echocardiography and Doppler ultrasound (Philips IE33, Netherlands) examinations were performed on the same day before CPX. Left ventricular ejection fraction (LVEF) was determined according to the recommendations of the European Association of Echocardiography \[[@b15-medscimonit-20-960]\].

Right heart catheterization
---------------------------

Right heart catheterization was performed 3 days after CPX. Pulmonary capillary wedge pressure (PCWP) and mean pulmonary artery pressure (mPAP) were determined with balloon flotation catheter (Edwards Lifesciences, USA). CI was determined by Frick method.

Statistical analyses
--------------------

Data were analyzed using SPSS 13.0 (SPSS Inc; Chicago IL). Continuous variables are presented as mean ±SD and categorical variables as a percentage. The *t* test was used to compare continuous variables. The chi-square test was used to compare categorical variables. Multivariate linear regression was used to determine pulmonary function differences and the changes in CPX parameters between the 2 groups. To correct for demographic differences between the 2 groups of patients, variables that were either biologically plausible and/or significantly different between groups in univariate analysis were entered into the multivariate model. *P*\<0.05 was considered statistically significant.

Results
=======

Demographic data from the 2 patient groups are presented in [Table 1](#t1-medscimonit-20-960){ref-type="table"}. Patients with left heart failure were older, had a higher proportion of men and smokers, and had a higher BMI. These findings could affect pulmonary function.

The anaerobic threshold (AT) was detectable in all patients. Among the patients with right heart failure, 21 showed EIS. [Table 2](#t2-medscimonit-20-960){ref-type="table"} shows the results of univariate analysis of pulmonary function. Patients with right heart failure had lower oxygen uptake (VO~2~), VT, FEV1, FVC, MVV, and PetCO~2~, and higher end-tidal partial pressure of O~2~ (PetO~2~) and VE/VCO~2~ at rest. Right heart failure patients had lower peak VO~2~, peak VE, peak VT, and peak PetCO~2~, and had higher peak VD/VT, peak PetO~2~, peak VE/VCO~2~, and VE/VCO~2~ slope during exercise. Right heart failure patients had lower ΔVO~2~, ΔVE, ΔPetCO~2~, and ΔVE/VCO~2~, from rest to exercise.

[Table 3](#t3-medscimonit-20-960){ref-type="table"} shows the result of multivariate regression analysis of pulmonary function. Patients with right heart failure had lower PetCO~2~, and higher PetO~2~ and VE/VCO~2~ at rest. Right heart failure patients had a lower peak PetCO~2~, and higher peak VD/VT, peak PetO~2~, peak VE/VCO~2~, and VE/VCO~2~ slope during exercise. Right heart failure patients had lower ΔPetCO~2~ and ΔVE/VCO~2~, from rest to exercise.

[Figure 1A](#f1-medscimonit-20-960){ref-type="fig"} shows the result of VD/VT ratio versus VE/VCO~2~ at rest. The curves show patients with right heart failure had higher VE/VCO~2~ and lower PetCO~2~ at any given VD/VT ratio at rest. [Figure 1B](#f1-medscimonit-20-960){ref-type="fig"} shows the result of peak PetCO~2~ versus VE/VCO~2~ slope. The abrupt curve of right heart failure was suggestive of EIS in the right heart failure patients during exercise. Most right heart failure patients had higher VE/VCO~2~ slope and peak VD/VT at any given peak PetCO~2~. [Figure 1C](#f1-medscimonit-20-960){ref-type="fig"} shows the result of peak VD/VT ratio versus VE/VCO~2~ slope. The curves show that most right heart failure patients had a lower PetCO~2~ and higher VD/VT ratio at any given.

Discussion
==========

Patients with right heart failure had lower PetCO~2~, and higher PetO~2~ and VE/VCO~2~ at rest. Patients with right heart failure showed a higher peak VD/VT, peak PetO~2~, peak VE/VCO~2~, and VE/VCO~2~ slope, and a lower PetCO~2~ during exercise. Patients with right heart failure had more changes in ΔPetCO~2~ and ΔVE/VCO~2~ from rest to exercise. These results show that patients with right heart failure had worse pulmonary function at rest and exercise.

Pulmonary function at rest
--------------------------

Pulmonary function changes compatible with restrictive lung disease are observed in most patients with severe CHF \[[@b16-medscimonit-20-960],[@b17-medscimonit-20-960]\], and findings compatible with airway obstruction are common in patients with right heart failure caused by idiopathic pulmonary arterial hypertension (IPAH) \[[@b18-medscimonit-20-960]\]. We did not observed any different ventilatory measures at rest in the 2 groups.

PetCO~2~ reflects ventricular function \[[@b19-medscimonit-20-960]\]. Right heart failure patients had a lower PetCO~2~ ([Table 3](#t3-medscimonit-20-960){ref-type="table"}, [Figure 1A](#f1-medscimonit-20-960){ref-type="fig"}). [Figure 1A](#f1-medscimonit-20-960){ref-type="fig"} shows that right heart failure patients had a lower PetCO~2~ at any given VD/VT. These results demonstrate that patients with right heart failure had more ventilation at given CO~2~ discharge. Considering there was no difference in respiratory frequency or VE, the lower PetCO~2~ was due to hyperventilation in alveolus with well-perfusion and hypoperfusion of well ventilated alveolus in patients with right heart failure \[[@b20-medscimonit-20-960],[@b21-medscimonit-20-960]\]. The lower PetCO~2~ could explain the higher VE/VCO~2~ in patients with right heart failure. The higher VE/VCO~2~ showed that right heart failure patients had lower ventilation efficiency. The higher PetO~2~ was a secondary effect of lower PetCO~2~.

The VD/VT ratio reflects the V/Q mismatching \[[@b20-medscimonit-20-960]\]. There was no difference in VD/VT ratio between the 2 groups. This result means that there was no difference in V/Q mismatching at rest in the 2 groups.

Pulmonary function during exercise
----------------------------------

PetCO~2~ was lower in both CHF and PAH, reflecting the ventilation impairment \[[@b3-medscimonit-20-960],[@b8-medscimonit-20-960],[@b20-medscimonit-20-960]--[@b25-medscimonit-20-960]\]. We found that right heart failure patients had a lower PetCO~2~ during exercise ([Table 3](#t3-medscimonit-20-960){ref-type="table"}). The reason for the lower peak PetCO~2~ during exercise in patients with right heart failure was similar to the reason for lower PetCO~2~ at rest. Sun et al. \[[@b14-medscimonit-20-960]\] found that patients with PAH had an EIS resulting in abrupt decreased PetCO~2~, had increased PetO~2~, and increased VE/VCO~2~ ratio during exercise. The abrupt curve of right heart failure demonstrated that patients with right heart failure had EIS ([Figure 1B](#f1-medscimonit-20-960){ref-type="fig"}). EIS also contributed to the lower peak PetCO~2~.

We found that patients with right heart failure had significantly higher peak VD/VT ratio ([Table 3](#t3-medscimonit-20-960){ref-type="table"}). [Figure 1C](#f1-medscimonit-20-960){ref-type="fig"} shows that most patients with right heart failure had a lower peak PetCO~2~ and a higher VE/VCO~2~ slope. These results demonstrate that patients with right heart failure had severe V/Q mismatching at peak exercise. This means that primary pulmonary vesicular damage played a greater role in V/Q mismatching during exercise than did pulmonary congestion. Moreover, the EIS was involved in the higher VD/VT in patients with right heart failure.

VE/VCO~2~ and VE/VCO~2~ slope are important to reflect disease severity and prognosis in CHF and PAH, and reflect V/Q mismatching in PAH \[[@b21-medscimonit-20-960],[@b25-medscimonit-20-960]\]. We found that peak VE/VCO~2~ and VE/VCO~2~ slope were higher in patients with right heart failure. These results demonstrate that patients with right heart failure had more severe ventilation inefficiency and gas exchange abnormality compared to patients with left heart failure. These results were due to lower peak PetCO~2~ and higher peak VD/VT in right heart failure patients.

Change in CPX parameters from rest to peak exercise
---------------------------------------------------

We found that patients with right heart failure had higher absolute values of ΔPetCO~2~ and ΔVE/VCO~2~ from rest to peak exercise ([Table 2](#t2-medscimonit-20-960){ref-type="table"} and [3](#t3-medscimonit-20-960){ref-type="table"}). These results show that right heart failure patients had larger changes of pulmonary function from rest to exercise. The larger change of ΔPetCO~2~ demonstrates that patients with right heart failure had more severe hyperventilation from rest to exercise. This should be attributed to more complex ventilation drive in PAH, including exercise-induced hypoxia and EIS \[[@b20-medscimonit-20-960]\].

We found that patients with right heart failure had worse ventilation efficiency, severe V/Q mismatching, and gas exchange abnormality, even without differences in peak VO~2~.

This study had some limitations. It was a single-center study and demographic differences were detected between the 2 groups. The etiology of heart failure in the 2 groups resulted in differences of sex and age. Because there was no control group, we could not confirm a normal breathing pattern at rest. We could not obtain diffusion function measures from all patients. This influenced the evaluation of pulmonary function. We could not perform invasive hemodynamic testing in all patients, which influenced our evaluation of left heart failure. We merged the 4 disease classes into 2 groups because there were not enough patients with class IV NYHA right heart failure.

Conclusions
===========

Patients with right heart failure had worse pulmonary function at rest and during exercise. The differences in pulmonary function at rest were due to different breathing patterns and worse gas exchange in patients with right heart failure. The differences during exercise were due to severe V/Q mismatching, EIS, alveolar ventilation disorder, and oxygenation dysfunction secondary to pulmonary vascular damage in patients with right heart failure.
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![(A) VD/VT ratio versus VE/VCO~2~ at rest. The curves showed that patients with right heart failure had a higher VE/VCO~2~ at any given VD/VT ratio at rest. (**B**) Peak PetCO~2~ versus VE/VCO~2~ slope. The abrupt curve of right heart failure was suggestive of EIS in the right heart failure patients during exercise. (C) Peak VD/VT ratio versus VE/VCO~2~ slope. The curves showed that most right heart failure patients had a lower PetCO~2~ at any given VD/VT ratio.](medscimonit-20-960-g001){#f1-medscimonit-20-960}

###### 

Baseline characteristics.

  Characteristic   Left heart failure (n=60)   Right heart failure (n=60)   P value
  ---------------- --------------------------- ---------------------------- ---------
  Men, n           53                          10                           \<0.001
  Age, years       45.1±9.9                    30.8±9.5                     \<0.001
  BMI, kg/m^2^     24.12±3.94                  22.13±2.95                   0.002
  Smokers, n       37                          4                            \<0.001
  NYHA, n                                                                   0.131
  Class I/II       18                          27                           --
  Class III/IV     42                          33                           --
  LVEF,%           27.92±8.99                  64.65±6.31                   \<0.001
  mPAP, mmHg       --                          54.35±16.91                  --
  PCWP, mmHg       --                          9.20±3.83                    --
  CI, L/min×m^2^   --                          1.99±0.22                    --
  ICM, n           13                          --                           --
  NICM, n          47                          --                           --
  IPAH, n          --                          44                           --
  FPAH, n                                      2                            
  APAH, n                                      14                           

ICM -- ischemic cardiomyopathy; NICM -- non-ischemic cardiomyopathy; IPAH -- idiopathic pulmonary arterial hypertension; FPAH -- familial pulmonary arterial hypertension; APAH -- associated with pulmonary arterial hypertension.

###### 

Univariate analysis of pulmonary function.

  Measure                        Left heart failure   Right heart failure   P valure
  ------------------------------ -------------------- --------------------- ----------
  Rest VO~2~, ml/min             341.82±97.65         285.07±67.69          \<0.001
  Rest VE, L/min                 11.09±3.16           10.42±2.75            0.214
  Rest VT, L                     0.68±0.20            0.59±0.22             0.028
  Rest FEV1, L                   2.89±0.57            2.55±0.59             0.001
  Rest FVC, L                    3.69±0.69            3.23±0.74             0.001
  Rest FEV1/FVC, %               79.28±5.41           79.25±7.70            0.984
  Rest MVV, L/min                118.27±28.62         97.17±27.12           \<0.001
  Rest Rf, b/min                 17.02±4.69           18.82±5.44            0.054
  Rest VD/VT, %                  31.40±5.62           31.67±4.69            0.778
  Rest PetCO~2~, mmHg            33.72±4.47           28.78±4.25            \<0.001
  Rest PetO~2~, mmHg             110.68±7.48          115.80±6.65           \<0.001
  Rest VE/VCO~2~, L/min/L/min    37.96±6.50           43.45±6.79            \<0.001
  Peak VO~2~, ml/min             1092.85±309.73       756.83±271.30         \<0.001
  Peak VE, L/min                 43.62±11.79          36.91±14.71           0.007
  Peak BR, %                     61.80±9.77           63.83±12.19           0.315
  Peak VT, L                     1.47±0.41            1.19±0.36             \<0.001
  Peak Rf, b/min                 30.30±6.01           31.24±8.04            0.468
  Peak VD/VT, %                  27.18±4.02           28.83±4.04            0.027
  Peak PetCO~2~, mmHg            33.42±6.04           24.32±5.30            \<0.001
  Peak PetO~2~, mmHg             117.17±6.10          124.43±5.61           \<0.001
  Peak VE/VCO~2~, L/min/L/min,   36.13±7.97           48.50±11.95           \<0.001
  VE/VCO~2~ slope                32.74±7.52           45.70±16.18           0.001
  EIS, n                         --                   21                    
  ΔVO~2~, %                      236.40±108.37        171.28±82.76          \<0.001
  ΔVE, %                         323.56±168.47        262.41±118.19         0.023
  ΔVT, %                         126.49±59.07         114.34±68.37          0.300
  ΔRf, %                         88.70±58.52          72.89±45.66           0.054
  ΔVD/VT, %                      −11.71±15.45         −7.72±14.21           0.300
  ΔPetCO~2~, %                   −0.61±14.16          −15.61±12.91          \<0.001
  ΔPetO~2~,%                     6.18±7.06            7.65±5.12             0.196
  ΔVE/VCO~2~, %                  4.55±16.28           −11.46±18.68          \<0.001

Rf -- respiratory frequency.

###### 

Multivariate regression analysis of pulmonary function.

  Measure                        β        P value
  ------------------------------ -------- ---------
  Rest VO~2~, ml/min             −0.052   0.700
  Rest VT, L                     0.058    0.687
  Rest FEV1, L                   −0.139   0.304
  Rest FVC, L                    −0.004   0.977
  Rest MVV, L/min                −0.049   0.705
  Rest Rf, b/min                 0.064    0.664
  Rest PetCO~2~, mmHg            −0.435   0.001
  Rest PetO~2~, mmHg             0.329    0.023
  Rest VE/VCO~2~, L/min/L/min    0.320    0.020
  Peak VO~2~, ml/min             −0.174   0.118
  Peak VE, L/min                 0.213    0.102
  Peak VT, L                     0.179    0.149
  Peak VD/VT,%                   0.376    0.010
  Peak PetCO~2~, mmHg            −0.704   \<0.001
  Peak PetO~2~, mmHg             0.655    \<0.001
  Peak VE/VCO~2~, L/min/L/min,   0.614    \<0.001
  VE/VCO~2~ slope                0.506    0.001
  ΔVO^2^, %                      −0.195   0.171
  ΔVE, %                         0.003    0.984
  ΔRf, %                         −0.081   0.591
  ΔPetCO~2~, %                   −0.657   \<0.001
  ΔVE/VCO~2~, %                  −0.622   \<0.001

Left heart failure = 0, right heart failure = 1, female = 0, male = 1, non-smoker = 0, smoker = 1.
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